Abstract
The physiological role of F 1F 0-ATPase inhibition in ischemia may be to retard ATP depletion although views of the significance of IF 1 are at variance. We corroborate here a method for measuring the ex vivo activity of F 1F 0-ATPase in perfused rat heart and show that observation of ischemic F 1F 0-ATPase inhibition in rat heart is critically dependent on the sample preparation and assay conditions, and that the methods can be applied to assay the ischemic and reperfused human heart during coronary by-pass surgery. A 5-min period of ischemia inhibited F 1F 0-ATPase by 20% in both rat and human myocardium. After a 15-min reperfusion a subsequent 5-min period of ischemia doubled the inhibition in the rat heart but this potentiation was lost after 120 min of reperfusion. Experiments with isolated rat heart mitochondria showed that ATP hydrolysis is required for effective inhibition by uncoupling. The concentration of oligomycin for 50% inhibition (I 50) for oxygen consumption was five times higher than its I 50 for F 1F 0-ATPase. Because of the different control strengths of F 1F 0-ATPase in oxidative phosphorylation and ATP hydrolysis an inhibition of the F 1F 0-ATPase activity in ischemia with the resultant ATP-sparing has an advantage even in an ischemia/reperfusion situation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biochimica et Biophysica Acta (BBA) - Bioenergetics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
